# [Corrigendum] Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines in vitro

**Authors:** Giovanni Vanni Frajese, Monica Benvenuto, Massimo Fantini, Elena Ambrosin, Pamela Sacchetti, Laura Masuelli, Maria Gabriella Giganti, Andrea Modesti, Roberto Bei

PMC · DOI: 10.3892/ol.2026.15494 · Oncology Letters · 2026-02-17

## Full-text entities

- **Genes:** MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, MAPK3 (mitogen-activated protein kinase 3) [NCBI Gene 5595] {aka ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** breast cancer (MESH:D001943)
- **Chemicals:** K (MESH:D011188), Corrigendum (-), ascorbic acid (MESH:D001205), A (MESH:D001151)
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930238/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12930238/full.md

---
Source: https://tomesphere.com/paper/PMC12930238